Automated synthesis, characterization and biological evaluation of [68Ga]Ga-AMBA, and the synthesis and characterization of natGa-AMBA and [67Ga]Ga-AMBA

Applied Radiation and Isotopes

Volumn 68, Issue 12, 2010, Pages 2285-2292

  Cagnolini, Aldo ^a   Chen, Jianqing ^a   Ramos, Kimberly ^a   Marie Skedzielewski, Tina ^a   Lantry, Laura E ^a   Nunn, Adrian D ^a   Swenson, Rolf E ^a   Linder, Karen E ^a  

^a Bracco Research USA   (United States)

Author keywords

67Ga; 68Ga; AMBA; Bombesin; Ga AMBA; Gallium

Indexed keywords

67GA; 68GA; AMBA; BOMBESIN; GA-AMBA;

CELL CULTURE; PEPTIDES; PURIFICATION;

GALLIUM;

AMBA GA NAT; AMBA GALLIUM GA 67; AMBA GALLIUM GA 68; AMBA INDIUM IN 111; AMBA LUTETIUM LU 177; GASTRIN RELEASING PEPTIDE RECEPTOR; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMATION; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG PURIFICATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG UPTAKE; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR AFFINITY;

ANIMALS; AUTOMATION; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GALLIUM RADIOISOTOPES; HUMANS; MALE; MICE; OLIGOPEPTIDES; PROSTATIC NEOPLASMS;

EID: 77956431127     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2010.06.023     Document Type: Article

References (30)

1. 68Ga-DOTATOC. Nucl. Med. Biol. 2008, 35:721-724.
2. Baum R., Prasad V., Mutloka M., Frischknecht N., Maecke H., Reubi J.-C. Molecular imaging of bombesin receptors in various tumors by Ga-68 AMBA PET/CT: first results. J. Nucl. Med. 2007, 48(Suppl. 2):79.
3. Bodei L., Ferrari M., Nunn A., Llull J-B, Cremonesi M., Martano L., Laurora G., Scardino E., Tiberini S., Bufi G, Eaton S., De Cobelli O., Paganelli G. Eur. J. Nucl. Med. Mol. Imaging 2007, 34(Suppl. 2):S221.
4. 68Ga. Eur. J. Nucl. Med. Mol. Imaging 2005, 33:478-485.
5. 177Lu-labeled radiotherapeutic compound, and NMR structural elucidation of the ligand and its Lu and Hf complexes. Inorg. Chem. 2009, 48(7):3114-3124.
6. 177Lu]Lu-AMBA, a systemic radiotherapeutic agent for gastrin releasing peptide receptor positive tumors. Appl. Radiat. and Isotopes 2008, 66:497-505.
7. 177Lu-AMBA. J. Nucl. Med. 2007, 48(Suppl. 2):306P.
8. Cuttitta F., Carney D.N., Mulshine J., Moody T.W., Fedorko J., Fischler A., Minna J.D. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature 1985, 316:823-826.
9. 68Ga-labelled peptides. Nucl. Med. Commun. 2007, 28(11):870-875.
10. Deshmukh M.V., Voll G., Kühlewein A., Mäcke H., Schmitt J., Kessler H., Gemmecker G. NMR studies reveal structural differences between the gallium and yttrium complexes of DOTA-D-Phe1-Tyr3-octreotide. J. Med. Chem. 2005, 48(5):1506-1514.
11. Erspamer V. Discovery, isolation and characterization of bombesin-like peptides. Bombesin-like Peptides in Health and Disease, Annals of the New York Academy of Sciences 1988, vol. 47:3-9.
12. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol. Imaging 2008, 3:67-77.
13. 177Lu-AMBA in PC-3 tumor bearing mice. J. Nucl. Med. 2007, 48(Suppl. 2):79P.
14. ICH Harmonised Tripartite Guideline. Impurities: Guideline for Residual Solvents (Q3C), July 1997. International Conference on Harmonisation.
15. 68Ga-DOTATOC: preliminary data. Eur. J. Nucl. Med. 2001, 28(12):1751-1756.
16. 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J. Nucl. Med. 2006, 47:1144-1152.
17. Linder K.E., Metcalfe E., Arunachalam T., Chen J., Eaton S.M., Feng W., Fan H., Raju N., Cagnolini A., Lantry L.E., Nunn A.D., Swenson R.E. In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites. Bioconj. Chem. 2009, 20(6):1171-1178.
18. 177Lu-AMBA in a low GRP receptor expression model of prostate cancer. J. Nucl. Med. 2009, 50(12):2017-2024.
19. Markwalder R., Reubi J-C. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res. 1999, 59:1152-1159.
20. 68Ga-labelled DOTA-derivatised peptide ligands. Eur. J. Nucl. Med. Mol. Imaging 2004, 31(8):1097-1104.
21. Rosman.K.J.R., Taylor P.D.P. International union of pure and applied chemistry in isotopic compositions of the elements. Pure Appl. Chem. 1997, 1998(70):217.
22. 68Ga-labeled bombesin(6-14) analog. J. Nucl. Med. 2005, 46(4):691-699.
23. Serdons K., Verbruggen A., Bormans G. The presence of ethanol in radiopharmaceutical injections. J. Nucl. Med. 2008, 49(12):2071.
24. 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues. Clin. Exp. Metastasis 2009, 26(2):105-119.
25. Vangsted A., Anderson E.V., Nedergaard L., Zeuthen J. Gastrin releasing peptide GRP (14-27) in human breast cancer cells and in small cell lung cancer. Breast Cancer Res. Treatment 1991, 19(2):119-128.
26. 68Ga bioconjugates with high specific radioactivity. Bioconj. Chem. 2004, 15:554-560.
27. 68Ga-labeled peptide. Nucl. Med. Biol. 2008, 35:529-536.
28. Viola N.A., Rarig R.S., Ouellette W., Doyle R.P. Synthesis, structure and thermal analysis of the gallium complex of 1,4,7,10-tetraazacyclo-dodecane-N,N',N",N"'-tetraacetic acid (DOTA). Polyhedron 2006, 25(18):3457-3462.
29. Zhang H., Schuhmacher J., Waser B., Wild D., Eisenhut M, Reubi J.C., Maecke H.R. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. Eur. J. Nucl. Med. Mol. Imaging 2007, 34(8):1198-1208.
30. 68Ga for medical application. J. Nucl. Med. 2007, 48(10):1741-1748.